Skip to main content
HR 1056 109th Congress House Crime and Law Enforcement Business records Chemicals Commerce Congress Congressional reporting requirements Data banks Drug abuse Drug industry Drug law enforcement Drug traffic Drugs Economics and Public Finance Electronic government information Federal aid to research Foreign Trade and International Finance Government Operations and Politics Government paperwork Government publicity Health

Methamphetamine Precursor Control Act of 2005

Introduced: March 2, 2005 See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 4, 2005
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Mar 14, 2005
Referred to the Subcommittee on Health.
Mar 2, 2005
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Mar 2, 2005
Introduced in House
 Plain-English summary Congressional Research Service

Methamphetamine Precursor Control Act of 2005 - Amends the Controlled Substances Import and Export Act to place limitations on the importation of ephedrine, pseudoephedrine, or phenylpropanolamine. Authorizes the Attorney General to: (1) request a distributor of a chemical in the chain of distribution to provide information on such distribution, including sales; and (2) issue an order, upon determining that a foreign-chain distributor is refusing to cooperate, prohibiting the importation of such substances.

Directs the Attorney General, acting through the Administrator of the Drug Enforcement Administration, to carry out a MethWatch program to provide information to retailers regarding the purchase of precursor products by individuals who may intend to use them in illicit methamphetamine production.

Amends the Controlled Substances Act to require the Attorney General to revoke the authority of a person whose registration includes authority regarding ephedrine, pseudoephedrine, or phenylpropanolamine, if such person has received four written notifications that the Attorney General considers the person to be in violation of the Act.

Requires a registration that includes authority for the sale of ephedrine or pseudoephedrine at retail to provide that the registration does not permit such a sale in which more than nine grams is sold in a single transaction. Prohibits knowingly or intentionally possessing more than 24 grams of pseudoephedrine unless specified conditions apply, such as the chemical is possessed for a legitimate medical purpose.

Authorizes additional funding to support research through the National Institutes of Health toward developing drug alternatives to pseudoephedrine.

What's happening now April 4, 2005

Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

 Committees of jurisdiction 4
 Cosponsors 1
All 1 Democratic 1